SCHIMMEL PAUL Insider Trading Activity

Average Profitability
27.77%
Insider Buys Quantity
3
Insider Buys Sum
$3.5M
Insider Sells Quantity
15
Insider Sells Sum
$25.32M

Insider Activity of SCHIMMEL PAUL

According to the SEC Form 4 filings, SCHIMMEL PAUL, being in a position of

  1. director at aTyr Pharma, Inc.,
    оver the last 12 months, has bought 100000 shares for $49,630, and sold 0 shares,
    over all time since 2024-07-22, has bought 1200000 shares for $1.15M, and sold 0 shares.

Biography of SCHIMMEL PAUL

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $49,6301100
Sells
 $000

Comparison of Insiders on Amount of Buys and Sells

2026-05-27PurchaseaTyr Pharma, Inc.
ATYR
director
100,000
0.1058%
$0.50$49,630+0.99%
2025-10-09PurchaseaTyr Pharma, Inc.
ATYR
director
317,999
0.4141%
$0.94$299,364-24.45%
2025-10-08PurchaseaTyr Pharma, Inc.
ATYR
director
682,001
0.8473%
$0.90$612,437-27.73%
2024-07-24PurchaseaTyr Pharma, Inc.
ATYR
director
52,300
0.1398%
$1.93$101,038+71.24%
2024-07-23PurchaseaTyr Pharma, Inc.
ATYR
director
6,648
0.0167%
$1.82$12,075+76.2%
2024-07-22PurchaseaTyr Pharma, Inc.
ATYR
director
41,052
0.0989%
$1.74$71,500+76.88%
2018-03-13SaleAlnylam Pharmaceuticals, Inc.
ALNY
director
55,646
0.0579%
$150.00$8.35M-35.36%
2015-04-21SaleAlnylam Pharmaceuticals, Inc.
ALNY
director
20,000
0.0255%
$130.02$2.6M-18.97%
2015-03-19SaleAlnylam Pharmaceuticals, Inc.
ALNY
director
18,106
0.0221%
$120.00$2.17M-13.41%
2015-03-17SaleAlnylam Pharmaceuticals, Inc.
ALNY
director
947
0.0003%
$27.28$25,834-10.71%
2014-12-08SaleAlnylam Pharmaceuticals, Inc.
ALNY
director
30,000
0.0241%
$63.55$1.91M-1.11%
2014-10-28SaleAlnylam Pharmaceuticals, Inc.
ALNY
director
30,000
0.0238%
$55.45$1.66M+10.79%
2014-01-13SaleAlnylam Pharmaceuticals, Inc.
ALNY
director
30,000
0.024%
$50.59$1.52M-22.12%
2013-12-20SaleAlnylam Pharmaceuticals, Inc.
ALNY
director
30,000
0.028%
$38.16$1.14M+4.61%
2013-10-22SaleAlnylam Pharmaceuticals, Inc.
ALNY
director
30,000
0.0284%
$34.65$1.04M+9.32%
2012-02-21PurchaseAlnylam Pharmaceuticals, Inc.
ALNY
director
186,046
0.3613%
$10.75$2M+41.4%
2009-09-10SaleAlnylam Pharmaceuticals, Inc.
ALNY
director
31,200
0.0744%
$22.26$694,578-24.04%
2009-09-09SaleAlnylam Pharmaceuticals, Inc.
ALNY
director
60,000
0.1444%
$22.10$1.33M-22.77%
2009-09-04SaleAlnylam Pharmaceuticals, Inc.
ALNY
director
58,800
0.1408%
$22.02$1.29M-22.86%
2007-12-04SaleAlnylam Pharmaceuticals, Inc.
ALNY
director
7,192
0.018%
$31.89$229,364-9.95%
Total: 23
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.